Risks ID'd for Referral-Warranted Retinopathy of Prematurity

Predictors include presence of preplus disease, retinal hemorrhage, need for ventilation

FRIDAY, Dec. 19, 2014 (HealthDay News) -- Predictors have been identified for referral-warranted (RW)-retinopathy of prematurity (ROP), according to research published online Dec. 18 in JAMA Ophthalmology.

Gui-Shuang Ying, Ph.D., from the University of Pennsylvania in Philadelphia, and colleagues examined predictive factors for the development of RW-ROP in a multicenter observational cohort.

The researchers found that 15.2 percent of the 979 infants without RW-ROP at first study-related eye examination who underwent at least two examinations developed RW-ROP. In multivariate analysis, the following were identified as significant predictors: male sex (odds ratio [OR], 1.80), nonblack race (OR, 2.76 for white; OR, 4.81 for other), low birth weight (OR, 5.16), younger gestational age (OR, 9.79), number of quadrants with preplus disease (OR, 7.12 for one to two quadrants; OR, 18.4 for three to four quadrants versus no preplus disease), stage 2 ROP (OR, 4.13), presence of retinal hemorrhage (OR, 4.36), the need for respiratory support (OR, 4.99 for controlled mechanical ventilator; OR, 11.0 for high-frequency oscillatory ventilation), and slow weight gain (OR, 2.44). The development of RW-ROP was predicted significantly better with these characteristics than with birth weight and gestational age (area under the receiver operating characteristic curve, 0.88 versus 0.78; P < 0.001).

"Using a model like the one presented here could help identify lower-risk infants who are less likely to develop RW-ROP and require less-frequent imaging or eye examinations," the authors write.

One author disclosed financial ties to Janssen Research and Development.

Abstract
Full Text (subscription or payment may be required)

Related Stories

No stories found.
logo
www.healthday.com